Cytek Biosciences Inc (CTKB)
Operating profit margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | -27,846 | -27,625 | -19,845 | -11,609 | -1,804 | -571 | 966 | 5,668 |
| Revenue (ttm) | US$ in thousands | 193,014 | 183,117 | 175,594 | 166,060 | 164,036 | 155,086 | 148,985 | 139,234 |
| Operating profit margin | -14.43% | -15.09% | -11.30% | -6.99% | -1.10% | -0.37% | 0.65% | 4.07% |
December 31, 2023 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-27,846K ÷ $193,014K
= -14.43%
The operating profit margin for Cytek Biosciences Inc has been fluctuating over the past eight quarters. It was negative in the most recent quarters, indicating that the company's operating expenses exceeded its gross profit, resulting in operating losses. The trend shows a deterioration in profitability, with the margin declining from positive figures in early 2022 to consistently negative values in 2023. This suggests that Cytek Biosciences Inc may be facing challenges in controlling its operating costs relative to its revenue generation. Further analysis of the company's cost structure and revenue streams may be necessary to identify areas for improvement and potential strategies for enhancing profitability.
Peer comparison
Dec 31, 2023